Mimedx Group earnings were -$19.2M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest MDXG earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$8.7M, down 41.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MDXG reported annual earnings of $48.6M, with 14.5% growth.
On MDXG's earnings call on Oct 28, 2026, Mimedx Group (NASDAQ: MDXG) reported Q3 2026 earnings per share (EPS) of -$0.06, up 154.55% year over year. Total MDXG earnings for the quarter were -$8.68 million. In the same quarter last year, Mimedx Group's earnings per share (EPS) was $0.11.
As of the last Mimedx Group earnings report, Mimedx Group is currently losing money. Mimedx Group's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$19.19 million, a 147.01% decrease year over year.
What was MDXG's earnings growth in the past year?
As of Mimedx Group's earnings date in Oct 28, 2026, Mimedx Group's earnings has grown year over year. MDXG earnings in the past year totalled -$19.19 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.